BELLAN, CRISTIANA
 Distribuzione geografica
Continente #
NA - Nord America 12.885
EU - Europa 10.852
AS - Asia 5.548
SA - Sud America 859
AF - Africa 304
Continente sconosciuto - Info sul continente non disponibili 304
OC - Oceania 20
Totale 30.772
Nazione #
US - Stati Uniti d'America 12.664
GB - Regno Unito 2.528
RU - Federazione Russa 2.004
CN - Cina 1.925
IT - Italia 1.839
SG - Singapore 1.644
IE - Irlanda 1.231
DE - Germania 734
BR - Brasile 713
SE - Svezia 657
UA - Ucraina 635
FR - Francia 552
VN - Vietnam 519
HK - Hong Kong 478
FI - Finlandia 282
KR - Corea 262
IN - India 163
BD - Bangladesh 158
ZA - Sudafrica 157
CA - Canada 122
TR - Turchia 106
NL - Olanda 66
PL - Polonia 63
ES - Italia 61
BE - Belgio 50
IQ - Iraq 50
AR - Argentina 48
MX - Messico 48
AT - Austria 39
JP - Giappone 32
ID - Indonesia 31
PK - Pakistan 31
CI - Costa d'Avorio 29
KE - Kenya 29
NG - Nigeria 29
EC - Ecuador 26
SA - Arabia Saudita 21
VE - Venezuela 21
CO - Colombia 20
MA - Marocco 18
CZ - Repubblica Ceca 16
UZ - Uzbekistan 15
AU - Australia 14
CL - Cile 13
MY - Malesia 12
GR - Grecia 11
JM - Giamaica 11
NP - Nepal 11
AZ - Azerbaigian 10
CH - Svizzera 10
IL - Israele 10
LT - Lituania 10
PT - Portogallo 9
RO - Romania 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
IR - Iran 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
EU - Europa 7
JO - Giordania 7
PA - Panama 7
UG - Uganda 7
CR - Costa Rica 6
EG - Egitto 6
LV - Lettonia 6
PE - Perù 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
KG - Kirghizistan 5
PH - Filippine 5
AM - Armenia 4
AO - Angola 4
BG - Bulgaria 4
KZ - Kazakistan 4
MT - Malta 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 30.445
Città #
Southend 2.290
Dallas 1.247
Dublin 1.193
Fairfield 1.037
Ashburn 973
Singapore 958
San Jose 741
Houston 714
Chandler 641
Santa Clara 635
Moscow 582
Jacksonville 539
Beijing 524
Woodbridge 500
Hong Kong 457
Milan 439
Siena 396
Wilmington 392
Seattle 359
Ann Arbor 346
Hefei 316
Cambridge 312
Council Bluffs 308
Seoul 259
Princeton 242
New York 239
Los Angeles 223
Menlo Park 216
Nanjing 185
The Dalles 177
Rome 165
Ho Chi Minh City 155
Johannesburg 143
Munich 140
Lauterbourg 130
Helsinki 101
Hanoi 95
Boardman 92
Florence 92
Buffalo 82
Dong Ket 77
Dearborn 76
São Paulo 75
Nanchang 74
Shanghai 73
San Mateo 72
Izmir 68
Columbus 66
San Diego 61
Chicago 58
Turku 55
Warsaw 51
Brussels 49
Figino 48
Orem 47
Málaga 44
Montreal 42
London 41
Shenyang 38
Bengaluru 37
Düsseldorf 37
Tianjin 34
Turin 34
Frankfurt am Main 33
Fremont 32
Toronto 32
Denver 31
Lappeenranta 31
Phoenix 31
Brooklyn 30
Redondo Beach 30
Abidjan 29
Atlanta 29
Bologna 29
Abuja 28
Hebei 28
San Francisco 28
Jiaxing 27
Changsha 26
Chennai 25
Kunming 24
Naples 24
Tokyo 24
Guangzhou 23
Sezze 23
Manchester 22
Belo Horizonte 21
Vienna 21
Amsterdam 20
Mexico City 20
Da Nang 19
Nuremberg 19
Stockholm 19
Falls Church 18
Haiphong 18
Jinan 18
Baghdad 17
Norwalk 17
Philadelphia 17
Poplar 17
Totale 20.792
Nome #
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach 578
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 413
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 368
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 359
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 358
Analisi del riarrangiamento e delle mutazioni del gene VH delle immunoglobuline nelle cellule B monocitoidi M-IRTA-1 positive. 357
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression 355
Frequent Traces of EBV Infection in Hodgkin and non-Hodgkin Lymphomas Classified as EBV-negative by Routine Methods: Expanding the Landscape of EBV-related Lymphomas 348
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 342
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 334
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 326
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 325
Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature 325
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues 323
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 319
Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity 310
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 310
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 307
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 299
Alteration of microRNAs regulated by c_Myc in Burkitt lymphoma 297
Identification of single-nucleotide variants by high-throughput RNA sequencing in endemic Burkitt Lymphoma 291
Burkitt lymphoma versus diffuse large B-cell lymphoma: A practical approach 282
EBV reactivation influences clonal evolution in HHV8 related lymphoprolipherative disorders? 281
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 279
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1 278
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas 270
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 268
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 268
Anaplastic large cell lymphomas and Hodgkin's disease: distinctive growth features and expression of p34cdc2 /cyclin B-1 267
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 266
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes 261
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas 258
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis 255
Gene expression analysis uncovers similarty and differences among Burkitt lymphoma subtypes 253
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? 253
Analysis of rearrangement and Vh gene mutations and correlation with the expression of M-IRTA 1 in monocytoid B cells of toxoplasmic lymphadenitis. 249
Burkitt’s lymphoma: new insights into molecular pathogenesis 248
Anaplastic large cell lymphomas and Hodkin’s disease: distinctive growth features and expression of p34cdc2/cyclin B-1 242
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 242
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. 241
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 236
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation 234
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 231
Activation of MyoD-dependent transcription by cdk9/cyclin T2 231
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 231
Immunoglobulin gene rearrangement analysis in composite Hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? 230
Altered expression of miRNAs in c-Myc negative Burkitt lymphoma cases 227
Oct-4 is highly expressed in stem/ progenitor cells and in primordial follicles of the fetal human ovary 226
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 224
Analysis of primary cilium expression and hedgehog pathway activation in mesothelioma throws back its complex biology 223
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 223
FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. 223
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 218
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 214
DNMT over-expression based on microRNA modulation in HIV-related aggressive B-cell lymphomas 213
Lymphoepithelial-like carcinoma of the parotid gland: a case report and a brief review of the western literature 213
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 212
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 212
Are periodontitis and psoriasis associated? A pre-clinical murine model 210
Cell growth and death in malignant lymphomas. A quantitative analysis 210
Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms 206
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 205
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis 204
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo 204
Pseudolymphoma of the kidney associated with high-grade bladder urothelial carcinoma 200
MicroRNA expression profile identifies a distinct molecular signature between MYC translocation-positive and negative Burkitt lymphoma cases 199
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection 197
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation 195
Retinoblastoma gene family expression in lymphoid tissues 194
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 194
Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation 192
Tumor-Suppressor Genes as Diagnostic Tools 192
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis 191
Cell kinetics and cell cycle regulation in lymphomas. 191
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations 189
Role of EBV in microRNA dysregulation in Burkitt lymphoma 189
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes 188
Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. 187
The XLMR gene ACSL4 plays a role in dendritic spine architecture 187
P53 mutation in breast cancer, correlation with cell kinetics and cell of origin 185
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 185
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 185
Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature. 183
Pathologic aspects of AIDS malignancies 182
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 181
TAVR and Dialysis Are a Challenging Combination. A Case Report and Systematic Review of Literature 181
Physical interaction between pRb and cdk9/cyclin T2 complex 180
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma (Cell Death & Disease, (2020), 11, 9, (748), 10.1038/s41419-020-02940-w) 180
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 178
Mesothelioma malignancy and the microenvironment: Molecular mechanisms 177
Humoral Rejection: The Pathologist’s Point of View 176
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 175
P53 mutation in breast cancer correlation with cell kinetics and cell of origin 173
Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior 172
Expression of p34(cdc2) and cyclin B-1 in Hodgkin's disease and anaplastic large cell lymphomas 172
Predictive prognostic factors of surgically treated intra-pulmonary mettstases from colorectal carcinomas: a 30 years retrospective analysis 169
Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA 168
The interaction between HIV-1 Tat and pRb2/p130: a possibile mechanisms in the pathogenesis of AIDS-related neoplasms. 168
Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples 165
null 164
Totale 24.049
Categoria #
all - tutte 92.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.491 0 0 112 204 103 65 86 127 74 193 140 387
2022/20232.448 145 211 338 336 243 477 50 214 236 66 80 52
2023/20241.910 77 48 194 69 58 576 627 27 30 55 23 126
2024/20254.006 98 217 383 206 559 213 86 222 336 161 437 1.088
2025/20269.991 739 1.297 1.034 1.190 1.880 359 1.099 316 334 525 340 878
2026/20271.194 410 349 435 0 0 0 0 0 0 0 0 0
Totale 30.772